Why the study?
Acute heart failure hospitalizations carry high rates of death and readmission, requiring summarized guidance on pre-discharge and early post-discharge management.
This ESC scientific statement emphasizes the critical window of pre-discharge and early post-discharge for optimizing guideline-directed medical therapy and managing congestion in acute heart failure patients.
Answers are grounded in this paper and cite their sources.
Emphasizes pre- and early post-discharge GDMT optimization and congestion management in acute HF; extends evidence synthesis into actionable transitional guidance.
Acute heart failure is a major cause of urgent hospitalizations. These are followed by marked increases in death and rehospitalization rates, which then decline exponentially though they remain higher than in patients without a recent hospitalization. Therefore, optimal management of patients with acute heart failure before discharge and in the early post-discharge phase is critical. First, it may prevent rehospitalizations through the early detection and effective treatment of residual or recurrent congestion, the main manifestation of decompensation. Second, initiation at pre-discharge and titration to target doses in the early post-discharge period, of guideline-directed medical therapy may improve both short- and long-term outcomes. Third, in chronic heart failure, medical treatment is often left unchanged, so the acute heart failure hospitalization presents an opportunity for implementation of therapy. The aim of this scientific statement by the Heart Failure Association of the European Society of Cardiology is to summarize recent findings that have implications for clinical management both in the pre-discharge and the early post-discharge phase after a hospitalization for acute heart failure.
No takes yet. Share an insight, caveat, or question.
Metra et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: